A RANDOMIZED STUDY OF THE INFLUENCE OF PERFUSION TECHNIQUE AND pH MANAGEMENT STRATEGY IN 316 PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY:II. Neurologic and cognitive outcomes -- Murkin et al. 110 (2): 349 -- The Journal of Thoracic and Cardiovascular Surgery - http://jtcs.ctsnetjournals.org/cgi...
"And when you think about how we currently produce meat, it couldn’t be more unnatural. It’s not natural to genetically breed chickens to have growth rates two to three times that of normal chickens, then put 10,000 of them in a metal shed, pump them full of growth-promoting drugs, and have them live in their own wastes. It’s not a particularly safe or efficient way of producing protein. On those terms, cultured meat looks pretty good."
- Nils Reinton
from Bookmarklet
But I wonder how they're going to generate the biomass, first in terms of feedstock (algae). I am also skeptical of any vegetarian who is trying to make "artificial" meat. Soilent Green!!
- Jim Hardy
"It couldn't be more unnatural..." - well as described, yes, but not all meat is high-intensity, factory-farmed. Or don't they have free-range in the USA?
- Neil Saunders
Also a bit skeptical to the promise of this technology to replace meat-production. Nice if this can eliminate vegetarians ;-) also like the possibility of eliminating the bacterial contamination risk...
- Nils Reinton
@Jim - assuming your comment wasn't tongue-in-cheek, why would you be skeptical? many vegetarians are so because they object to the way the animals are treated. treatment which, in many cases, makes them much less healthy to eat - which is another reason behind vegetarianism. so why wouldn't a vegetarian be just as capable as an omnivore to drive this technology? (OTH if you meant your comment purely to set up the Soylent Green punchline, than I apologize - that did make me chuckle ;-)
- tim
@Nils other than the objections raised in the article, which are formidable, what makes you skeptical? people won't eat it if they know it's in vitro? political will to revamp the food industry isn't there? or some technological weakness?
- tim
@tim in addition to your points on political will and consumer skepticism, it seems to me that there are huge technological obstacles (like vascularization also mentioned in the article). Lastly, I don't think traditional meat producers are just happily going to roll over and die.
- Nils Reinton
"Lastly, I don't think traditional meat producers are just happily going to roll over and die". Quite. Slightly OT, but cue 'Soylent Green' featuring Heston C et al - http://www.youtube.com/watch...
- Graham Steel
@Nils I agree. but if they can sell it to the food industry - cheaper to produce, safer, smooth transition to new pipeline, profits to be had...well, call me idealistic but I still have a shred of hope. (technology seems to me to be a smaller hurdle, but maybe I'm just jaded.)
- tim
@Graham @Jim I loved Charlton Heston in Soylent Green. =)
- tim
American Journal of Transplantation - Abstract: Volume 6(6) June 2006 p 1473-1478 Pulsatile Perfusion Reduces the Incidence of Delayed Graft Function in Expanded Criteria Donor Kidney Transplantation. - http://pt.wkhealth.com/pt...
The influence of pulsatile and nonpulsatile extracorporeal circulation on fluid retention following coronary artery bypass grafting -- Thompson et al. 7 (3): 201 -- Perfusion - http://prf.sagepub.com/cgi...
Does anyone have any experience in removing residual E. coli proteins (~10% of total protein) from a partially (90%) purified recombinant? AFAIK there are no useful tags on the recombinant so removal will have to focus on the E coli proteins, e.g. protein G beads + anti-E.coli polyclonal.
Depends a bit on the yield of recombinant. Has it been through ion-exchange (e.g. miniQ) and gel filtration (e.g. S200/S75, depends on size) already? Those are the usual first steps for non-tagged.
- Neil Saunders
This is something I'm buying at 4mg/ml, 90% pure -- meaning, I presume, that 0.4mg/ml is E. coli crap and 3.6 mg/ml is my recombinant. I don't know what purification steps have already been used -- I am trying to track that info down -- my guess would be that it's just the usual suspects -- ammonium sulfate cut, size exclusion, HPLC (RP or ion). That's why I'm thinking in terms of home-made affinity columns as above.
- Bill Hooker
And no, for various reasons I can't just buy a better product! :-)
- Bill Hooker
At this point (assuming size, pI, etc has been tried), it sounds like you'd be better off cooking up a chromatography step based on affinity to the recombinant (e.g. substrate analog, etc) rather than broad immunoprecip. towards the contaminants.
- Wladimir Labeikovsky
Wladimir, the protein has no activity so there's no substrate -- I could use an antibody, but why do you think it would be better to try to recover the 90% target than to try to yank out the 10% contaminant? I wasn't thinking of straight immunoprecip, rather a protein G column + polyclonal + crosslinking = affinity column for the contaminants, e.g. http://cshprotocols.cshlp.org/cgi...
- Bill Hooker
I should add that I'll be trying to clean up 20-50 mg at a time, if I can scale up that far. That's why I thought to focus on the E. coli crap -- less to bind.
- Bill Hooker
My first step would be to run a gel on it. You may find that that 10% isn't even protein but salt and nucleic acids. Then I would try in order: Size exclusion, ion exchange, hydrophobic interaction chromatography to see if they help you clean it up or not. SEC probably not so good on a 20mg scale but the others can be done in batch mode in good old Buchner funnels.
- Cameron Neylon
I have some gels run by my "predecessors" on earlier batches -- they do show faint Coomassie stainable bands in addition to the strong band of my target protein. There may be some NA but at least some of the crud is protein. The reason the crud is a problem is that this is to be used to assay for anti-(target protein) antibodies in human serum, and 10% of such serum contains antibodies against various E. coli proteins, which gives a false positive readout in the assay.
- Bill Hooker
As others have said, I'd run an ion exchange first (mainly because it's fast) and see how far that gets you, then move to a size-exclusion column if you think you have enough mass separation. You could also consider running a quick mass spec or something similar on the supplied material to get a better handle on the impurities.
- Jason Winget
the protein G column is worth trying if you have it set up already but there's no guarantee at all that it would catch the particular contaminants you have
- Wladimir Labeikovsky
Adding my voice to the rest - column sep is the way to go at first, just to get a feel for it.
- Mr. Gunn
@MrG, do you mean ion exchange? And can anyone recommend a good resin for that? (I have a peristaltic pump but I don't know if it's in good working order...)
- Bill Hooker
At pH > pI, protein net charge (-), anion exchange (e.g. mini Q). pH < pI, protein net charge (+), cation exchange (e.g. mini S). Also recommend a friend with an FPLC setup :-)
- Neil Saunders
Oh yeah -- I don't know *exactly* what the recombinant is. Some genius stuck me with this; it's a commercial product, one manufacturer and one distributor (who know they have us over a barrel) and so all I know is that it "encompasses a portion" of a particular protein. So I can't even predict pI from sequence. We're skint so HPLC/FPLC is out of the question... I know people with rigs but I'm loath to impose to the necessary degree (testing, optimisation, scale-up...).
- Bill Hooker
Hmm, problematic. So I guess SDS-PAGE (as others suggested) will give you monomeric size and so an indication of the best size exclusion column. Can you do 2D-PAGE to estimate pI? Presumably your protein will be the "major spot". Option 3: see where it comes down in ammonium sulphate cut and from there, hydrophobic interaction column.
- Neil Saunders
As above, I have SDS-PAGE images -- and only now I realize, the apparent size tells me that it's most if not all of the protein in question. So I *can* guesstimate pI from sequence.... it's just over 5, most likely. So at a nice physiological 7.4, anion exchange it is. If I go that way. Why are y'all bastards so against my proteinG+polyclonal idea?
- Bill Hooker
My worry would be that a polyclonal for all E.coli could (a) miss some and (b) cross-react with the recombinant.
- Neil Saunders
Ah, crap -- important point that I thought I had put in the first couple of comments: the polyclonal I propose to use is the one that is also used in an EIA to measure the degree of E. coli contamination in the antigen. When the EIA reactivity gets below a certain threshold, the antigen is useable in the product for which it's intended. So I can be confident the polyclonal won't miss anything I care about or pull out the recombinant.
- Bill Hooker
Note that all of my info comes from fragmentary notes left behind by my predecessors, so some/all of it might be garbage. So I'm grateful not only for criticism of the polyclonal idea, but also for all the various alternatives being put forward. I need to solve this problem pronto so I think I will run at least two approaches in parallel. As of now I'm leaning towards Mini-Q and the polyclonal thingy, the latter probably as a simple batch IP initially and then on a column if that isn't good enough.
- Bill Hooker
Isn't using the same using the same polyclonal produce sort of a circular argument for quality? Also, the anecdotal experience in my former lab was that sera that performed well in one application may not work well under another application with different conditions. That said, it looks like you're in a pickle, and the pull-down approach may be your best bet.
- Brian Haugen
"...produce sort of a circular argument for quality?" -- yes, it does rather. And also yes, my experience has been that sera don't always work well in multiple applications. The saving grace is that I don't have to clean this stuff up *extensively* so the polyclonal thing might work. I *think* it's how the cleanup was done previously... as I mentioned, I have only fragmentary records to work from.
- Bill Hooker
Muchas, muchas gracias for all the input, folks. (And keep the ideas coming, if any more occur to you!)
- Bill Hooker
Bill, if you have a polyclonal "scavenger" you can buy just buy some S Avidin beads and biotinylate the Ab. It's pretty simple and could be done in "batch" mode in buchner funnel, as Cameron suggested. Also, activated resin from Thermo http://is.gd/2FYzg (and others) allows you to link you Ab to resin and would work the same way. SA + Biotinylated Ab would be the old school way of doing it.
- Jim Hardy
Jim, would streptavidin/biotin be better than simply using proteinA/G beads with the unmodified Ab?
- Bill Hooker
SA/Biotin is higher capacity than ProteinG and it's more robust, but the difference might not be noticeable for your application. Sorry I missed your clarification request earlier, but Neil sorted you out on that as well as I could have. Regarding the circular argument - I think you're probably fine here, but there's no guarantee that what works for measurement will work for purification. It probably will, you'll just have to use a lot of it.
- Mr. Gunn
It arrived today. Have a stack of PLoS t-shirts in various sizes/designs. I now need to think of a cool way to give them away to folks that will wear 'em (I already have 4) . Any ideas?
- Graham Steel
Wore mine from #sbcPA yesterday. All the non-science peeps needed explainations.
- Jim Hardy
@ Ricardo, (you is as subtle as a brick shaped object) what size are you? I'll trade you one for a Mendeley one :)
- Graham Steel
Since I've yet to hear back from Dave M, plan T is now underway. Here are the shirts http://www.flickr.com/photos... Top row middle is now winging it's way off to Dr H Gee of Nature.com http://twitter.com/McDawg... even though, this might be rejected via i-stone !!. Ricardo V (shirt size yet to be disclosed) might have another (he has 12 hours left to comment) , so there are still four avaliable for free from me as matters stand. Code = ask politely/candidly. #PLOS
- Graham Steel
After what I suffered in the link posted above, I think I would be extremely happy to have a new PLoS T. Thanks!
- Paulo Nuin
Paulo, one can still do S, or L or XL. (One XL one went to someone in Cromer). Name your size and it will be shipped. ONLY three left now and you folks must try harder to convince me give this stuff away, err convincingly. (Each pack will contain other PLoS goodies too).
- Graham Steel
I will take the L. Can you send me an email with whatever you need? Maybe it's too far for you to ship :-)
- Paulo Nuin
And the L will be shipped to Paulo later in the month. So what's left? After a re-count, 2 S and 1 XL. Rather than simply giving the last 3 away in the manner thus far, one shall devise a competition and three lucky winners will get the last of the pickings.
- Graham Steel
Hmmm - somehow this comment thread dropped off my first few FF pages... Good luck with the competition, I might be a M but I'm not a S, so I'll pass :)
- Allyson Lister
Competition Idea ! As matters stand, me thinks it's boiling down to some form of pub quiz thang down in the, err pub after Science Online London http://www.scienceonlinelondon.org/blog... It will last for 5 - 10 mins and will be called "Who's Round Is It Anyway" Whilst the rules will be made up as we go along, the Host (not me) will ensure 'fair-play'. Cheating will be allowed within reason. 10 Prizes up for grabs inc. a priceless mystery top prize !! #solo09
- Graham Steel
Graham - I'll happily take you up on the trade-for-Mendeley shirt! :-) Yes yes yes!
- Victor / Mendeley Team
Game on. Must dash - I have a train to catch...whooosh
- Graham Steel
I recently posted on researchblogging.org and have published in PLoS ONE. Does that qualify me for one of the red or black ones in size M?
- Karen James
Did I read Mendeley shirt? (am actually wearing one of my PLoS One shirts right now...)
- Björn Brembs
By the time I got round to playing "Who's Round Is It Anyway" most folks had gone, so I adopted a new strategy under the circumstances. In the end, the priceless mystery top prize was won (at random I hasten to add) by Brian Kelly:- http://farm3.static.flickr.com/2664... On Monday, 2 shirts went to Victor and Jan @ Mendeley. Thanks guy's for the Mendeley shirt in return...
- Graham Steel
"The Personal Genome Project is an open-ended research study that aims to improve our understanding of genetic and environmental contributions to human traits. We are enrolling members of the public who are willing to share their genome sequence and other personal information with the scientific community and the general public."
- Shirley Wu
from Bookmarklet
I'm debating whether to apply for enrollment. Obviously, the open aspect of it is very cool. But this isn't kidding around - medical history and personal information become public domain (CC-0!): http://www.personalgenomes.org/public.... It's not an extension of yourself going open (i.e. your research), it's _you_... and I need to think a little more about the implications.
- Shirley Wu
Yeah, it's why I haven't done it yet. Just haven't had the time to think through the implications
- Deepak Singh
But your name will not end up in the CC0 data, will it? Why should I care if my digital copy ends up in that data set if no one would be able to link that to me? Got to read the ToS right now...
- Egon Willighagen
I suspect that the level of detail of information allows one to infer who it may be. Specially medical information. Also, from what I've seen, they take head shots of each person (with a little measuring tape on the forehead for scale!) :)
- Ricardo Vidal
I signed up for more info in the first phase, but have been sitting on my invite. As cool as it would be, I'm not sure the risks outweigh the rewards, at least until better protections are put into place. GINA is a start, but there's much work to be done.
- Chris Miller
Egon, I've spoken to enough people who say that you don't need a name with whole genome data to figure out whom it belongs to. I will likely end up doing it since I don't care even if they had my name up there, but just from the conceptual standpoint, it's good to understand.
- Deepak Singh
Right, there is definitely more than enough information to connect you to your data. In fact, just the zip code, sex, and DOB are enough to identify 87% of people in a de-identified database (saw this stat yesterday, can't remember where), and for PGP you've got a fairly complete medical history as well as photos. I'm pretty torn about this because I really think a large, open database...
more...
- Shirley Wu
You also have to worry about the privacy of your kids, I think, even if they're not born yet...very frustrating and confusing issue!
- Steve Koch
I signed up months ago and have passed the first qualifying tests. On to level two, for consideration as one of the PGP100 or PGP1000 if I don't make the first cut. I have no fears of my DNA being exposed.
- Jim Hardy
@Jim, I assume that means you also have no problem with people knowing your medical history, including, hypothetically, potentially "too much information" about, say, that anal fissure you had a year ago or your chronic irritable bowel syndrome?
- Shirley Wu
Right, Shirley. It's mainly the fear of losing insurance that deters me. Without a good social safety net for healthcare in the US, I can't justify releasing information that could prevent me or my future offspring from getting quality medical care.
- Chris Miller
I wonder how many friendfeed and Facebook users like me have made a conscious decision to divide professional and private social networking between these respective services.
Yeah, which is why I do not want a Facebook account... Facebook, MySpace, etc, is for non-working contacts... FriendFeed I use for collegues, not 'friends' or family...
- Egon Willighagen
introduces the possibility of isolating and growing MSCs of different capacities for different clinical applications or drug discovery
- Jim Hardy
from Bookmarklet
Good data advancing the cause of afterbirth derived SCs
- Jim Hardy
rvidal on There is a growing consensus (at least in Silicon Valley) that the information age is about to give way to the era of synthetic genetics. - http://www.reddit.com/r...
"I understand Craig Venter's importance in the Human Genome project, however it was a massive project done in conjunction with a very large group of scientists, not just himself. I do believe he's done quite a lot with his "fame" and fortune. Namely his expeditions and work with marine/ocean microorganisms. However, as I stated before, in my opinion George Church has done more hardcore and groundbreaking science."
- Ricardo Vidal
Venter's ego really gets in the way. No one really likes him in Rockville and pretty sure he's banned from Bethesda. Knew a lot of people who worked for him. He took credit for everything. George Church is an unassuming, Professor-type and much more likable. Probably a much more skilled scientist, too.
- Jim Hardy
I want to write a post "Stem cell nutrition (aka enhancers) is bullshit" Would you participate?
- Alexey
@Alexey, sure. Sounds like fun. Someone needs to take these guys down with data and facts. Trying to think how a "homeopathic" stem cell therapy might work. Take one ES cell, dilute it 10^10 with normal skin cells and DMEM. Administer rectally. Yeah, that's the ticket. I think that should work.
- Jim Hardy
"As a sperm biologist of 20 years' experience, I am unconvinced from the data presented in this paper that the cells produced ... can be accurately called 'Spermatozoa.' "
- Jim Hardy
from Bookmarklet
The retraction is based on allegations of plagiarism (a paragraph taken from another paper I think), I do not think the data is in dispute...the authors never claimed that they had made "sperm cells or spermatozoa or spermatogonia...." but rather cells with sperm like qualities. This is one retraction I wouldn't be too worried about.
- Nils Reinton
"Johns Hopkins University School of Medicine in Baltimore, MD, report that transplanting a new line of stem cell-like cells into rat models"
- Jim Hardy
from Bookmarklet
Abstract | Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model - http://www.biomedcentral.com/1471-23...
I thought it was a pretty funny little piece. I liked it.
- Jim Hardy
I also liked the podcast, for it's content. I just couldn't stand the way the guy was talking. Sounded like he was reading and not very fluidly. I probably read the same but then again, I don't host a podcast.
- Ricardo Vidal
A BRIEF COMMUNICATION: Human Term Placenta as a Source of Hematopoietic Cells -- Serikov et al. 234 (7): 813 --
Experimental Biology and Medicine
doi: 10.3181/0809-BC-262 - http://www.ebmonline.org/cgi...
Stem Cell Research: Fate Therapeutics: A Further Look At Academic Stem Cell Researchers And The Private Sector That Will Market Their Results - http://www.stemcelldigest.net/stemcel...
Fate's strategy is to try and take advantage of what we're learning about stem-cell biology to develop methods of using drugs to turn on or turn off stem cells
- Jim Hardy
from Bookmarklet
great approach, one of companies that I'm watching
- Alexey
I just heard their CTO speak at the San Diego Biotech Network meeting today. Got permission to blog about it and talked to him for a while about my dissertation, which was, as it happens, on the use of small molecules to manipulate adult stem cell differentiation.
- Mr. Gunn
Alexey, he asked me to forward my resume to him, so hopefully he'll followup if there's real interest. There's probably few people in the world who are a better fit than me for one of their positions.
- Mr. Gunn
"Academics, like teenagers, sometimes don’t have any sense regarding the degree to which they are conformists"- Provocative!
- Jim Hardy
from Bookmarklet
Scientists are humans, too. We need to keep reminding ourselves of it. Like the Romans, where the guy holding the laurel wreath for the successful general during the victory parade through Rome was always repeating : "remember, you're only human".
- Björn Brembs
Mandy Rice-Davies applies, but I would argue that the solution is to show your data. You are unlikely to slide down the peer-->maverick-->pariah slope if your data are good and your reasoning sound; the most anyone will do is disagree with you, and say why, but they will still respect you.
- Bill Hooker
@Bill: The most anyone will do is (respectfully) not give you that grant/position :-)
- Eric Jain
Industrial postdocs - what's your take? A cynical attempt to get in on the academic-style exploitation of highly skilled people, or a great place to do research and get paid well, too?
Funny. I hired a Cornell Hopkins PhD postdoc (Andy Fire was on PhD committee) for $60K in 2005. Was being paid $40K at Hopkins. That's 50% pay raise. Worth at least $100, but market (academia) dictates the market (and not just for postdocs)
- Jim Hardy
so industry does look to academia postdoc salary as a guide? That kinda seems wrong. I mean, academia isn't appreciated for the pay, but you do have more autonomy.
- Mr. Gunn
I don't know that they look to academic salaries as a guide, they just know perfectly well that at a salary they consider a bargain, the postdoc is still getting a huge raise compared to academia. Perhaps the better question is: does industry have a postdoc trap too? Is it possible to dead-end the way postdocs usually do in academia?
- Bill Hooker
Bill, that's kinda what I was asking. I had the first interview of what's apparently quite a process today for a postdoc with GNF. http://gnf.org While they said they were very interested in the professional development of people in this position, when I asked what kinds of institution-sponsored professional development things were available, they couldn't tell me much. The most...
more...
- Mr. Gunn
Andrew Su (http://friendfeed.com/asu) works at GNF -- I'm sure he wouldn't mind if you sent him a few questions by email. He's on LinkedIn so maybe you have a connection, too.
- Bill Hooker
"Over the past year, Harvard’s endowment has collapsed (it lost $8 billion between last July and October), its fundraising has declined, and its construction cranes have been idled."
- Alexey
from Bookmarklet
Interesting. Construction continues like mad at Hopkins.
- Jim Hardy
Still building at Univ of Michigan as well despite the dire straights of the state...just doubled research space with buy of Pfizer campus (30 buildings!!)
- Carey Lumeng